Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
暂无分享，去创建一个
S. Galetta | T. Ziemssen | H. Butzkueven | J. Frederiksen | Stefanie H. Freeman | L. Balcer | G. Jaffe | L. Massacesi | F. Ziemssen | Lei Xu | D. Cadavid | O. Aktas | L. Vanopdenbosch | Y. Chai | M. Skeen | Mark B. Skeen